National
Clock is ticking for N.J. marriage bill
The only out lawmaker in the New Jersey Legislature said the state’s pending marriage legislation “could go either way” and cautioned against bringing the bill to a vote if supporters don’t think they have sufficient support.
Reed Gusciora, a gay Democrat and sponsor of the marriage bill in the Assembly, said in an interview with DC Agenda that prospects of passing the legislation dimmed after Gov. Jon Corzine (D) failed in his bid for re-election last month and following losses for same-sex marriage in Maine and New York.
“It could go either way,” he said. “A lot of legislators, unfortunately, are taking a second look at the issue. … There’s always an argument not to do it and to fall in line with these other states.”
Even so, Gusciora, who’s also deputy majority leader of the Assembly, said New Jersey has a chance of passing same-sex marriage because of the Garden State’s liberal leanings.
“It still has a shot because New Jersey, at the end of the day, is a fairly progressive state,” he said. “It’s just a matter of my colleagues voting for the bill, which otherwise they should have.”
Supporters of gay nuptials are under the gun to pass same-sex marriage. Corzine has said he’d sign marriage legislation if it reaches his desk, but his failure to win re-election means he’ll soon leave the governor’s mansion. On Jan. 19, his successor, Republican Chris Christie will take office, and he’s pledged to veto any same-sex marriage bill that passes the legislature.
On Monday, Christie reiterated his opposition to the marriage bill in response to criticism from rock star and New Jersey-native Bruce Springsteen, according to Newark’s Star-Ledger, although Christie’s opposition wasn’t as emphatic as it has been in the past.
“This is where the people of New Jersey obviously have differences of opinion,” Christie was quoted as saying. “There are lots of people who feel very strongly about same-sex marriage and believe it should be the law of the state, and there are lots of folks like me who believe that it shouldn’t.”
Steven Goldstein, chair of Garden State Equality, declined to describe his organization’s efforts to pass the marriage legislation in the weeks before Christie takes office, saying he didn’t want to tip off opponents to his activities.
“I can inform your audience, which is mostly outside of New Jersey, or I could do what we’re doing, which is continue to work hard to win marriage equality and keep our strategy close to the vest, and that’s what I prefer to do,” he said.
Still, he said he would agree with Gusciora’s assessment that the marriage bill “could go either way,” calling it “an innocuous enough statement.”
“That can be interpreted as anything, so why not agree?” he said.
Gusciora said he thinks the legislature will take up the marriage bill in January when lawmakers return from the holiday recess. He noted that he’s expecting the Assembly to consider the legislation first, followed by action in the Senate.
The State Senate Judiciary Committee last week approved the marriage legislation, 7-6. A Senate floor vote on the bill was initially scheduled for last week, but postponed after supporters said they wanted to wait until the Assembly had public hearings.
Mike BeLoreto, Gusciora’s chief of staff, said he thinks the bill has “a good chance” of passing the Assembly, but in the Senate the situation is “still very close to call.”
“We obviously have more Democratic votes in the Assembly than they do in the Senate, so it gives us a wider margin if some members need to jump off for their own political or personal reasons,” BeLoreto said.
As for the Senate, BeLoreto said a favorable vote in the Assembly “will end up spurring some progress on the Senate side.”
Democrats hold a majority in the State Senate, 23-17. Senate President Richard Codey has said the bill lacks unanimous support among the Democratic caucus and Republican votes are needed to pass the legislation.
Charles Moran, a Log Cabin Republicans spokesperson, said his organization isn’t formally lobbying for the marriage bill because his group doesn’t have a chapter in New Jersey.
Nonetheless, he said he plans to send out an action alert to his group’s members in the state to encourage them to lobby their officials.
“We’re going to start sending out some blasts to all our internal lists of Republicans and say, ‘Contact these state senators and identify yourself as a Republican in support marriage equality,’” he said.
Moran said his group has identified five Senate Republicans that could vote to pass the bill. One is Bill Baroni, the Republican Judiciary Committee member who voted in favor of the legislation, and another is Jennifer Beck, who voted against the legislation in committee but said she’d consider voting for it on the Senate floor.
Gusciora said the bill should be enacted into law as a matter of fairness.
“We recognize Newt Gingrich’s three wives, Rudy Giuliani’s three wives and Britney Spears’ 72 hours of nuptials — and there are plenty of same-sex couples that have been together a lot longer,” Gusciora said. “They pay taxes like everyone else, they raise families, they’re allowed to adopt in this state, so it’s a matter of fairness.”
Still, Gusciora urged advocates not to hold a vote on the bill if support is uncertain.
The wide margin of failure of the marriage bill in the New York State Senate earlier this month, 24-38, spurred some people to question why a vote was taken if there wasn’t an assurance of greater support.
“I’m not into taking names,” Gusciora said. “We already know who’s against it, so I don’t think we have to take the vote. The other thing is that if there isn’t a vote, there’s always an opportunity to revisit the issue, so I would rather us not take the vote.”
Gusciora said the New Jersey state courts could take up the matter should lawmakers fail to act. While no marriage litigation is pending in New Jersey, Gusciora noted that someone could bring the issue before judges.
In 2006, the New Jersey Supreme Court ruled that the legislature needed to create some form of relationship recognition for same-sex couples in New Jersey. In response, civil unions were enacted.
“[You] wouldn’t want conservatives to get to say, ‘You had your shot in the legislature, so why are you taking it to the courts?’” Gusciora said. “The court can always revisit the issue and say, ‘You didn’t go far enough — it should indeed be called marriage.’”
But if lawmakers fail to approve the marriage legislation before Jan. 19, Gusciora said it would be “unlikely” that same-sex marriage will happen in New Jersey legislatively before Christie leaves office.
“He said that he would veto the bill if it ever came to his desk, so it’s unlikely in the four or eight years he’ll be governor that he would sign it,” he said. “Things always change with everybody, but he was pretty emphatic.”
Goldstein said he didn’t want to comment on whether the marriage bill could pass during the Christie administration if lawmakers in the upcoming weeks don’t approve the legislation.
“We’re working day and night to pass marriage equality while Jon Corzine is governor,” Goldstein said.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Your guide to D.C.’s queer New Year’s Eve parties
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Using movement to boost your mental health during holidays
Reasons to be optimistic about 2026
America is going in the wrong direction for intersex children
Rush reopens after renewing suspended liquor license
Long-awaited ‘Pillion’ surpasses the sexy buzz
